Atlas Trials

Dolutegravir + Rilpivirine Switch Study (DORISS)

Clinical trial NCT02069834 · WITHDRAWN

Trial details

NCT number
NCT02069834
Sponsor
Nantes University Hospital
Status
WITHDRAWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
HIV InfectionHAART-treatedVirologically Controlled
Start date
2014-05-01
Primary completion
2017-10-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.